nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—QPRT—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.0217	0.0753	CbGpPWpGaD
Niacin—Fungal skin infection—Riluzole—amyotrophic lateral sclerosis	0.0182	0.0332	CcSEcCtD
Niacin—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.0178	0.0326	CcSEcCtD
Niacin—Hernia—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0295	CcSEcCtD
Niacin—SLC5A8—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.0156	0.0541	CbGpPWpGaD
Niacin—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.0155	0.0282	CcSEcCtD
Niacin—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.015	0.0275	CcSEcCtD
Niacin—SLC16A3—hindbrain—amyotrophic lateral sclerosis	0.0143	0.0871	CbGeAlD
Niacin—QPRT—nervous system—amyotrophic lateral sclerosis	0.0133	0.0813	CbGeAlD
Niacin—SLC5A8—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.0133	0.046	CbGpPWpGaD
Niacin—QPRT—Nicotinate metabolism—PTGS2—amyotrophic lateral sclerosis	0.0131	0.0455	CbGpPWpGaD
Niacin—QPRT—central nervous system—amyotrophic lateral sclerosis	0.0128	0.0782	CbGeAlD
Niacin—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0233	CcSEcCtD
Niacin—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.0126	0.023	CcSEcCtD
Niacin—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0228	CcSEcCtD
Niacin—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.0121	0.022	CcSEcCtD
Niacin—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0205	CcSEcCtD
Niacin—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.011	0.0201	CcSEcCtD
Niacin—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0196	CcSEcCtD
Niacin—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0192	CcSEcCtD
Niacin—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0187	CcSEcCtD
Niacin—QPRT—brain—amyotrophic lateral sclerosis	0.0102	0.0621	CbGeAlD
Niacin—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0184	CcSEcCtD
Niacin—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00983	0.0179	CcSEcCtD
Niacin—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00975	0.0178	CcSEcCtD
Niacin—SLC5A8—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00918	0.0318	CbGpPWpGaD
Niacin—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.0087	0.0159	CcSEcCtD
Niacin—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.0084	0.0153	CcSEcCtD
Niacin—NNMT—medulla oblongata—amyotrophic lateral sclerosis	0.00836	0.051	CbGeAlD
Niacin—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00829	0.0151	CcSEcCtD
Niacin—SLC16A3—brainstem—amyotrophic lateral sclerosis	0.00819	0.0499	CbGeAlD
Niacin—Gout—Riluzole—amyotrophic lateral sclerosis	0.00813	0.0148	CcSEcCtD
Niacin—SLC5A8—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00781	0.0271	CbGpPWpGaD
Niacin—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.0075	0.0137	CcSEcCtD
Niacin—NNMT—spinal cord—amyotrophic lateral sclerosis	0.00745	0.0455	CbGeAlD
Niacin—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.0072	0.0132	CcSEcCtD
Niacin—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00697	0.0127	CcSEcCtD
Niacin—SLC5A8—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00674	0.0234	CbGpPWpGaD
Niacin—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00665	0.0121	CcSEcCtD
Niacin—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00633	0.0116	CcSEcCtD
Niacin—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0063	0.0115	CcSEcCtD
Niacin—NNMT—nervous system—amyotrophic lateral sclerosis	0.00628	0.0383	CbGeAlD
Niacin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00613	0.0112	CcSEcCtD
Niacin—NNMT—central nervous system—amyotrophic lateral sclerosis	0.00605	0.0369	CbGeAlD
Niacin—NNMT—cerebellum—amyotrophic lateral sclerosis	0.00591	0.036	CbGeAlD
Niacin—NNMT—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00583	0.0202	CbGpPWpGaD
Niacin—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00581	0.0106	CcSEcCtD
Niacin—SLC16A3—medulla oblongata—amyotrophic lateral sclerosis	0.00571	0.0348	CbGeAlD
Niacin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00567	0.0103	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00551	0.0101	CcSEcCtD
Niacin—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00546	0.00998	CcSEcCtD
Niacin—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00542	0.0099	CcSEcCtD
Niacin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00532	0.00971	CcSEcCtD
Niacin—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00524	0.00956	CcSEcCtD
Niacin—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00928	CcSEcCtD
Niacin—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00919	CcSEcCtD
Niacin—SLC5A8—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00493	0.0171	CbGpPWpGaD
Niacin—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00486	0.00887	CcSEcCtD
Niacin—NNMT—brain—amyotrophic lateral sclerosis	0.0048	0.0293	CbGeAlD
Niacin—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00479	0.00875	CcSEcCtD
Niacin—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00476	0.00869	CcSEcCtD
Niacin—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00476	0.00869	CcSEcCtD
Niacin—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00464	0.00847	CcSEcCtD
Niacin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00458	0.00836	CcSEcCtD
Niacin—NNMT—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.00446	0.0155	CbGpPWpGaD
Niacin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00438	0.00801	CcSEcCtD
Niacin—SLC16A3—nervous system—amyotrophic lateral sclerosis	0.00429	0.0262	CbGeAlD
Niacin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00414	0.00755	CcSEcCtD
Niacin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00414	0.00755	CcSEcCtD
Niacin—SLC16A3—central nervous system—amyotrophic lateral sclerosis	0.00413	0.0252	CbGeAlD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.0041	0.0142	CbGpPWpGaD
Niacin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00743	CcSEcCtD
Niacin—SLC16A3—cerebellum—amyotrophic lateral sclerosis	0.00404	0.0246	CbGeAlD
Niacin—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00699	CcSEcCtD
Niacin—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00698	CcSEcCtD
Niacin—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00696	CcSEcCtD
Niacin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00696	CcSEcCtD
Niacin—SLC5A8—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.0038	0.0132	CbGpPWpGaD
Niacin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00379	0.00692	CcSEcCtD
Niacin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00685	CcSEcCtD
Niacin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00356	0.0065	CcSEcCtD
Niacin—HCAR2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00356	0.0123	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00349	0.0121	CbGpPWpGaD
Niacin—SLC16A1—medulla oblongata—amyotrophic lateral sclerosis	0.00347	0.0212	CbGeAlD
Niacin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00631	CcSEcCtD
Niacin—Chills—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00624	CcSEcCtD
Niacin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0034	0.00622	CcSEcCtD
Niacin—HCAR3—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00337	0.0117	CbGpPWpGaD
Niacin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00615	CcSEcCtD
Niacin—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00334	0.0116	CbGpPWpGaD
Niacin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00332	0.00606	CcSEcCtD
Niacin—SLC16A3—brain—amyotrophic lateral sclerosis	0.00328	0.02	CbGeAlD
Niacin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00597	CcSEcCtD
Niacin—Tension—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00594	CcSEcCtD
Niacin—SLC5A8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00324	0.0112	CbGpPWpGaD
Niacin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00588	CcSEcCtD
Niacin—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.0032	0.0195	CbGeAlD
Niacin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00582	CcSEcCtD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00311	0.0108	CbGpPWpGaD
Niacin—SLC16A1—spinal cord—amyotrophic lateral sclerosis	0.00309	0.0189	CbGeAlD
Niacin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00553	CcSEcCtD
Niacin—SLCO2B1—medulla oblongata—amyotrophic lateral sclerosis	0.00298	0.0182	CbGeAlD
Niacin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00544	CcSEcCtD
Niacin—SLC5A8—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00298	0.0103	CbGpPWpGaD
Niacin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00543	CcSEcCtD
Niacin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00542	CcSEcCtD
Niacin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00535	CcSEcCtD
Niacin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00532	CcSEcCtD
Niacin—Cough—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00529	CcSEcCtD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00283	0.00981	CbGpPWpGaD
Niacin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00516	CcSEcCtD
Niacin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00516	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00512	CcSEcCtD
Niacin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00504	CcSEcCtD
Niacin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00494	CcSEcCtD
Niacin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00494	CcSEcCtD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00268	0.0093	CbGpPWpGaD
Niacin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00486	CcSEcCtD
Niacin—SLCO2B1—spinal cord—amyotrophic lateral sclerosis	0.00266	0.0162	CbGeAlD
Niacin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00482	CcSEcCtD
Niacin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00263	0.0048	CcSEcCtD
Niacin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00478	CcSEcCtD
Niacin—NNMT—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00261	0.00905	CbGpPWpGaD
Niacin—SLC16A1—nervous system—amyotrophic lateral sclerosis	0.00261	0.0159	CbGeAlD
Niacin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00471	CcSEcCtD
Niacin—NNMT—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00257	0.00893	CbGpPWpGaD
Niacin—QPRT—Disease—TPK1—amyotrophic lateral sclerosis	0.00257	0.00891	CbGpPWpGaD
Niacin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00462	CcSEcCtD
Niacin—SLC16A1—central nervous system—amyotrophic lateral sclerosis	0.00251	0.0153	CbGeAlD
Niacin—QPRT—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—amyotrophic lateral sclerosis	0.00251	0.0087	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00247	0.0045	CcSEcCtD
Niacin—SLC16A1—cerebellum—amyotrophic lateral sclerosis	0.00245	0.015	CbGeAlD
Niacin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00447	CcSEcCtD
Niacin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00444	CcSEcCtD
Niacin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00441	CcSEcCtD
Niacin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00439	CcSEcCtD
Niacin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00435	CcSEcCtD
Niacin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0043	CcSEcCtD
Niacin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00427	CcSEcCtD
Niacin—Pain—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00423	CcSEcCtD
Niacin—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.0023	0.00798	CbGpPWpGaD
Niacin—SLCO2B1—nervous system—amyotrophic lateral sclerosis	0.00224	0.0137	CbGeAlD
Niacin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00404	CcSEcCtD
Niacin—SLCO2B1—central nervous system—amyotrophic lateral sclerosis	0.00216	0.0132	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00215	0.00747	CbGpPWpGaD
Niacin—QPRT—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00215	0.00746	CbGpPWpGaD
Niacin—QPRT—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00215	0.00746	CbGpPWpGaD
Niacin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00393	CcSEcCtD
Niacin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00391	CcSEcCtD
Niacin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00391	CcSEcCtD
Niacin—SLCO2B1—cerebellum—amyotrophic lateral sclerosis	0.00211	0.0129	CbGeAlD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00209	0.00723	CbGpPWpGaD
Niacin—QPRT—Disease—VTA1—amyotrophic lateral sclerosis	0.00205	0.00712	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00204	0.00708	CbGpPWpGaD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.002	0.00695	CbGpPWpGaD
Niacin—NNMT—Metabolism—TPK1—amyotrophic lateral sclerosis	0.002	0.00694	CbGpPWpGaD
Niacin—NNMT—Metabolism—VAPB—amyotrophic lateral sclerosis	0.002	0.00694	CbGpPWpGaD
Niacin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00364	CcSEcCtD
Niacin—SLC16A1—brain—amyotrophic lateral sclerosis	0.00199	0.0121	CbGeAlD
Niacin—SLC22A5—medulla oblongata—amyotrophic lateral sclerosis	0.00198	0.0121	CbGeAlD
Niacin—QPRT—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00197	0.00682	CbGpPWpGaD
Niacin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00355	CcSEcCtD
Niacin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00192	0.0035	CcSEcCtD
Niacin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00338	CcSEcCtD
Niacin—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00183	0.0112	CbGeAlD
Niacin—NNMT—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00183	0.00634	CbGpPWpGaD
Niacin—QPRT—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00183	0.00634	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00183	0.00633	CbGpPWpGaD
Niacin—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.0018	0.00626	CbGpPWpGaD
Niacin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00327	CcSEcCtD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00177	0.00615	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00177	0.00615	CbGpPWpGaD
Niacin—SLC22A5—spinal cord—amyotrophic lateral sclerosis	0.00177	0.0108	CbGeAlD
Niacin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00314	CcSEcCtD
Niacin—QPRT—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00172	0.00596	CbGpPWpGaD
Niacin—SLCO2B1—brain—amyotrophic lateral sclerosis	0.00171	0.0105	CbGeAlD
Niacin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00312	CcSEcCtD
Niacin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00311	CcSEcCtD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.0017	0.00591	CbGpPWpGaD
Niacin—NNMT—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.0017	0.0059	CbGpPWpGaD
Niacin—Headache—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0031	CcSEcCtD
Niacin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00294	CcSEcCtD
Niacin—NNMT—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0016	0.00554	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00158	0.00548	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00158	0.00548	CbGpPWpGaD
Niacin—QPRT—Disease—CHMP2B—amyotrophic lateral sclerosis	0.00156	0.0054	CbGpPWpGaD
Niacin—QPRT—Metabolism—DAO—amyotrophic lateral sclerosis	0.00156	0.00539	CbGpPWpGaD
Niacin—HCAR2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00155	0.00538	CbGpPWpGaD
Niacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00155	0.00538	CbGpPWpGaD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00152	0.00527	CbGpPWpGaD
Niacin—HCAR3—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00147	0.0051	CbGpPWpGaD
Niacin—NNMT—Metabolism—DAO—amyotrophic lateral sclerosis	0.00145	0.00501	CbGpPWpGaD
Niacin—QPRT—Disease—PLB1—amyotrophic lateral sclerosis	0.00141	0.00488	CbGpPWpGaD
Niacin—SLC22A5—cerebellum—amyotrophic lateral sclerosis	0.0014	0.00855	CbGeAlD
Niacin—SLC16A3—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00127	0.00439	CbGpPWpGaD
Niacin—QPRT—Disease—VCP—amyotrophic lateral sclerosis	0.00125	0.00435	CbGpPWpGaD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00123	0.00428	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00122	0.00422	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00122	0.00422	CbGpPWpGaD
Niacin—QPRT—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00118	0.00409	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00118	0.00408	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00117	0.00406	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00115	0.004	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00114	0.00395	CbGpPWpGaD
Niacin—SLC22A5—brain—amyotrophic lateral sclerosis	0.00114	0.00694	CbGeAlD
Niacin—HCAR2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00111	0.00383	CbGpPWpGaD
Niacin—NNMT—Metabolism—PLB1—amyotrophic lateral sclerosis	0.0011	0.0038	CbGpPWpGaD
Niacin—QPRT—Metabolism—GSR—amyotrophic lateral sclerosis	0.00109	0.00377	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00108	0.00375	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00105	0.00363	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00104	0.00359	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00102	0.00353	CbGpPWpGaD
Niacin—NNMT—Metabolism—GSR—amyotrophic lateral sclerosis	0.00101	0.00351	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000986	0.00342	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000977	0.00339	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000977	0.00339	CbGpPWpGaD
Niacin—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000961	0.00586	CbGeAlD
Niacin—SLCO2B1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000961	0.00333	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00094	0.00326	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000931	0.00323	CbGpPWpGaD
Niacin—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000925	0.00564	CbGeAlD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000923	0.0032	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00092	0.00319	CbGpPWpGaD
Niacin—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000904	0.00551	CbGeAlD
Niacin—QPRT—Disease—CST3—amyotrophic lateral sclerosis	0.0009	0.00312	CbGpPWpGaD
Niacin—QPRT—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000893	0.0031	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000893	0.0031	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000891	0.00309	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000866	0.003	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000866	0.003	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000861	0.00299	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000853	0.00296	CbGpPWpGaD
Niacin—NNMT—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00083	0.00288	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00083	0.00288	CbGpPWpGaD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00082	0.00284	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000817	0.00283	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00081	0.00281	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000791	0.00274	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000781	0.00271	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000772	0.00268	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000768	0.00266	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000768	0.00266	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000744	0.00258	CbGpPWpGaD
Niacin—CYP2D6—brain—amyotrophic lateral sclerosis	0.000734	0.00448	CbGeAlD
Niacin—SLC22A5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000734	0.00255	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000728	0.00252	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000706	0.00245	CbGpPWpGaD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000705	0.00245	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000705	0.00244	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000683	0.00237	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00066	0.00229	CbGpPWpGaD
Niacin—QPRT—Disease—CASP9—amyotrophic lateral sclerosis	0.000655	0.00227	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000653	0.00226	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000635	0.0022	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000626	0.00217	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000619	0.00215	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000619	0.00215	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000615	0.00213	CbGpPWpGaD
Niacin—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000602	0.00209	CbGpPWpGaD
Niacin—QPRT—Disease—ERBB4—amyotrophic lateral sclerosis	0.00056	0.00194	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000551	0.00191	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00055	0.00191	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000546	0.00189	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000535	0.00186	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000531	0.00184	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000527	0.00183	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000527	0.00183	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000526	0.00183	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000526	0.00183	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000517	0.00179	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000504	0.00175	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000494	0.00171	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000494	0.00171	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000482	0.00167	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000482	0.00167	CbGpPWpGaD
Niacin—QPRT—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00048	0.00167	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000473	0.00164	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000469	0.00163	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000468	0.00162	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000468	0.00162	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000457	0.00159	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000449	0.00156	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000448	0.00156	CbGpPWpGaD
Niacin—NNMT—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000446	0.00155	CbGpPWpGaD
Niacin—QPRT—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000441	0.00153	CbGpPWpGaD
Niacin—QPRT—Disease—APOE—amyotrophic lateral sclerosis	0.000433	0.0015	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000428	0.00149	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000425	0.00147	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000422	0.00146	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000421	0.00146	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000417	0.00145	CbGpPWpGaD
Niacin—NNMT—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00041	0.00142	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000406	0.00141	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000402	0.00139	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000402	0.00139	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000401	0.00139	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000399	0.00138	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000381	0.00132	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00038	0.00132	CbGpPWpGaD
Niacin—QPRT—Metabolism—APOE—amyotrophic lateral sclerosis	0.000363	0.00126	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000358	0.00124	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000343	0.00119	CbGpPWpGaD
Niacin—NNMT—Metabolism—APOE—amyotrophic lateral sclerosis	0.000337	0.00117	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000336	0.00116	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000325	0.00113	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000322	0.00112	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000306	0.00106	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000297	0.00103	CbGpPWpGaD
Niacin—QPRT—Disease—PTGS2—amyotrophic lateral sclerosis	0.000297	0.00103	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000289	0.001	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000285	0.000988	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00027	0.000937	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000267	0.000925	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000267	0.000925	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000265	0.00092	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000252	0.000872	CbGpPWpGaD
Niacin—QPRT—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000249	0.000863	CbGpPWpGaD
Niacin—NNMT—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000231	0.000802	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000219	0.000761	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000219	0.00076	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000219	0.00076	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000218	0.000756	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000208	0.000721	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.0002	0.000695	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000192	0.000665	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000189	0.000656	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000181	0.000629	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000169	0.000585	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000166	0.000575	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—APOE—amyotrophic lateral sclerosis	0.000165	0.000572	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.00016	0.000555	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000159	0.000553	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000151	0.000524	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000147	0.00051	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000147	0.00051	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000143	0.000497	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000136	0.000471	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000134	0.000466	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000125	0.000433	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000118	0.000411	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000118	0.000408	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000117	0.000407	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000113	0.000392	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000108	0.000375	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000108	0.000375	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000106	0.000368	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000103	0.000356	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—amyotrophic lateral sclerosis	8.95e-05	0.00031	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—APOE—amyotrophic lateral sclerosis	8.9e-05	0.000309	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	8.05e-05	0.000279	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	7.43e-05	0.000258	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	6.1e-05	0.000212	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.1e-05	0.000211	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.28e-05	0.000114	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.01e-05	0.000104	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	2.48e-05	8.6e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.7e-05	5.89e-05	CbGpPWpGaD
